HUMA Humacyte, Inc.: institutional ownership and insider trading
171 funds reported holding $68.9M of Humacyte, Inc. in their latest 13F filings; in Q2 2026 funds net bought $11.8M, with 40 new positions and 33 funds selling out; over the last 12 months insiders bought $90.0K and sold $82.6K on the open market.
Famous investors holding HUMA
- Izzy Englander (Millennium Management): $1.49M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $1.46M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $23.1K, 0.0% of the portfolio
Largest institutional holders of HUMA
- VANGUARD GROUP INC — $8.09M
- ANTIPODES PARTNERS Ltd — $7.88M
- VANGUARD CAPITAL MANAGEMENT LLC — $7.88M
- Alyeska Investment Group, L.P. — $4.70M
- DAVIDSON KEMPNER CAPITAL MANAGEMENT LP — $3.90M
- BlackRock, Inc. (BLK) — $3.78M
- GREAT POINT PARTNERS LLC — $2.93M
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $2.25M
- UBS Group AG (UBS) — $2.22M
- AQR CAPITAL MANAGEMENT LLC — $2.03M
Recent HUMA insider trades
- Sep 14, 2026: Jones Keith Anthony bought 10,000 shares ($5.60K)
- Aug 20, 2026: Jones Keith Anthony bought 10,000 shares ($6.90K)
- Aug 17, 2026: Jones Keith Anthony bought 30,000 shares ($17.7K)
- May 19, 2026: Sebelius Kathleen bought 56,818 shares ($50.0K)
5%+ owners
- Fresenius Medical Care AG: 9.9% (Schedule 13D/A, filed Oct 16, 2025)